To get deals in your inbox each morning, sign up for our Term Sheet newsletter
Venture Capital DealsNuCana Biomed, a British developer of oncology therapeutics, has raised $57 million in Series B funding. Sofinnova Ventures led the round, and was joined by existing backers Sofinnova Partners, Morningside Ventures, Alida Capital and the Scottish Investment Bank. www.nucanabiomed.comTendyne Holdings Inc., a Roseville, Minn.-based developer of technologies for transcatheter mitral valve replacement, has raised $25 million in Series MORE